Changes in the liver fibrosis-related markers in breast cancer patients with a FIB-4 index of >2.30 during anastrozole treatment. by Kazuyoshi Ohkawa (836847)

Subjects:

Clinical features and cancer treatment in patients with breast cancer receiving letrozole and anastrozole. by Kazuyoshi Ohkawa (836847)

Subjects:

Exploring Metalloproteome Remodeling in Calprotectin-Stressed Acinetobacter baumannii Using Chemoproteomics by Maximillian K. Osterberg (22514185)

Subjects:

S1 Data - by Kazuyoshi Ohkawa (836847)

Subjects:

Heat and stress-related transcription factors under 1-MCP and HNT interaction effect in Antonio. by Wardah K. Mustahsan (17484456)

Subjects:

Clinical course of patient no. by Kazuyoshi Ohkawa (836847)

Subjects:

Lists of differentially expressed genes and gene ontology (GO) enrichment analysis under ambient versus high night-time temperatures with 1-MCP application. by Wardah K. Mustahsan (17484456)

Subjects:

Total number of applications to each discipline grouped by (a) clinical disciplines, (b) diagnostic disciplines, and (c) surgical disciplines. by Lucy Hui (17538542)

Subjects:

The expression differences of ethylene-related genes and transcription factors of HNT effect with MCP application. by Wardah K. Mustahsan (17484456)

Subjects:

Gene ontology (GO) enrichment analysis under high night-time temperatures with and without 1-MCP application. by Wardah K. Mustahsan (17484456)

Subjects:

Number of applicants matched to each discipline grouped by (a) clinical disciplines, (b) diagnostic disciplines, and (c) surgical disciplines. by Lucy Hui (17538542)

Subjects:

Trends in full immunization coverage among two-year-olds in Sierra Leone, 2008-2019. by Umaru Sesay (18982263)

Subjects:

Inequalities in full immunization coverage among two-year-olds in Sierra Leone, 2008-2019. by Umaru Sesay (18982263)

Subjects:

Trends in full immunization coverage among two-year-olds in Sierra Leone, 2008-2019. by Umaru Sesay (18982263)

Subjects:

The impact of MDA on hookworm prevalence and intensity of infection stratified by treatment with IDA or DA. by Jannet A. Tobon Ramos (20855642)

Receiver operating characteristic curve for anti-NIE antibodies for <i>S. stercoralis.</i> by Jannet A. Tobon Ramos (20855642)

“…The seroprevalence did not significantly decrease following DA treatment. These results include all individuals sampled, irrespective of whether they took the medications. …”

NIE ELISA results. by Jannet A. Tobon Ramos (20855642)

“…Twelve months post-MDA, hookworm prevalence decreased to 56.5% in DA- and 34.4% in IDA-treated villages, respectively (<i>p</i><0.001, both comparisons). …”

Kato Katz and PCR database 12 months collection. by Jannet A. Tobon Ramos (20855642)

“…Twelve months post-MDA, hookworm prevalence decreased to 56.5% in DA- and 34.4% in IDA-treated villages, respectively (<i>p</i><0.001, both comparisons). …”

Master database baseline, 4 weeks and 1 year. by Jannet A. Tobon Ramos (20855642)

“…Twelve months post-MDA, hookworm prevalence decreased to 56.5% in DA- and 34.4% in IDA-treated villages, respectively (<i>p</i><0.001, both comparisons). …”

Breaking strength and ash contents in the tibia. by Miloš Skřivan (5122037)

Subjects: